Has Paul Glazer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,090,556 in general payments to Paul Glazer, MD across 306 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Glazer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Glazer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Glazer, MD

Orthopaedic Surgery of the Spine · Chestnut Hill, MANPI 1750321287

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,413,674 of the $2,090,556 with a category attached, or 67.6%. Alphatec Spine, Inc accounts for 67.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $689,691 and has fallen 68.4% since, to $217,950 in 2025. Among orthopaedic surgery of the spine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,090,556in general payments, 2019–2025

Across 306 payments — averaging $6831.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alphatec Spine, Inc$1.4M
Globus Medical$670K
Zimmer Biomet$10K
Orthofix Medical, Inc.$3K
Arthrex$1K
Surgalign Spine Technologies, Inc.$619
plus $1K from 7 others

What the payments were for

Royalty or licence$1,413,67468%
Consulting fees$348,44317%
Speaking & faculty fees$253,53712%
Travel & lodging$63,2473%
Food & beverage$11,6561%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alphatec Spine, Inc	188	$1,405,787
Globus Medical(2 entities)	63	$669,683
Zimmer Biomet	17	$9,779
Orthofix Medical, Inc.	13	$2,560
Arthrex	7	$1,096
Surgalign Spine Technologies, Inc.	8	$619
Cerapedics Inc.	4	$376
Pacira Pharmaceuticals Incorporated	1	$187
Highridge Medical LLC	1	$180
Zimvie Inc.	1	$148
Nuvasive Specialized Orthopedics, Inc.	1	$89
Smith+Nephew	1	$30
Seaspine Orthopedics Corporation	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Other - Miscellaneous$719,018
RELINE$250,122
Solus ALIF$42,563
INVICTUS OPEN$34,455
LIF$31,869
ALIF$26,725
IMPERIAL$12,500
AMP$8,229
DO NOT USE - Cervical$8,033
Biomet SpinalPak$7,650
KODIAK$5,500
MULTIPLE$2,640
Graft Delivery System$2,051
Modulus$1,500
A/R Femoral Nail$1,500
Bone Healing Product Portfolio$1,159
Cervical$1,090
SafeOp$1,026
MIS Corpectomy$875
I-FACTOR PEPTIDE ENHANCED BONE GRAFT$846

How this compares

$2,090,556 in reported general payments places this provider in the 95th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$157,298

Medicare patients

127

Services billed

433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	14	$117
Cyclobenzaprine Hcl	21	$74
Tramadol Hcl	14	$41
Meloxicam	26	$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Chestnut Hill

Raymond HwangChestnut Hill$1.1M
Stephen ParazinChestnut Hill$4K
Robert BancoWellesley Hills$661K
Mitchell HardenbrookHopedale$542K
Steven LeckiePlymouth$316K
Jeremy ShorePeabody$232K
Richard OzunaPeabody$198K
Nikhil ThakurNorth Andover$118K
Chadi TannouryBoston$81K
Bryce BasquesRaynham$72K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →